Compare Agilent Technologies Inc (A) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.22B), while iShares 10 20 Year Treasury Bond ETF trades at $96.55. The key difference: Agilent Technologies Inc pays a 0.68% dividend while iShares 10 20 Year Treasury Bond ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| A | TLH | |
|---|---|---|
Market Cap | $42.22B | — |
Sector | Health | Fixed Income |
52-Week High | $157.20 | $105.36 |
52-Week Low | $110.24 | $96.39 |
Enterprise Value | $43.77B | — |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLH trades at $97.05 with minimal daily movement (+0.23%), showing technical bearish signals from moving averages while oscillators remain neutral. The stock maintains consistent dividend payments, with recent payouts of $0.41, $0.36, and $0.38 per share. Market sentiment reflects broader bond market concerns as Treasury yields rise amid inflation uncertainty and geopolitical tensions.
The outlook remains cautious with bearish technical indicators dominating and macroeconomic pressures from rising interest rates. Dividend stability provides some support, but the stock faces headwinds from bond market volatility and inflation concerns that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
